A comparison of the effects of plasma exchange and immunoadsorption on anti-insulin antibody synthesis in rabbits.
Plasma exchange (PE) and ex vivo immunoadsorption (IA) may be applicable to the removal of anti-insulin antibodies (AI-Ab) from diabetic patients. However, the removal of antibodies may prompt an increase in their rate of synthesis and an overshoot of antibody levels which may be deleterious to the patient. The effects of both PE and IA on AI-Ab synthesis were studied in a rabbit model. Rabbits were immunized with insulin and the resulting AI-Abs removed by both plasma exchange and specific immunoadsorption. Following AI-Ab removal by PE no increase in AI-Ab synthesis or antibody overshoot occurred. However a large increase in AI-Ab synthesis and overshoot occurred following specific AI-Ab removal by immunoadsorption. Despite similar reductions in AI-Ab levels by PE and IA, no increase in antibody synthesis occurred due solely to antibody removal. It is likely that antigen released from the immunoadsorbent stimulated the increase in antibody synthesis following immunoadsorption. These findings are relevant to the clinical application of both PE and IA.
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D005260:Female; D007163:Immunosorbent Techniques; D007328:Insulin / Q000097:blood; D007330:Insulin Antibodies / Q000096:biosynthesis* / Q000302:isolation & purification; D010951:Plasma Exchange; D011817:Rabbits
D001786:Blood Glucose; D007328:Insulin; D007330:Insulin Antibodies